Please login to the form below

Not currently logged in
Email:
Password:

Srdjan Stankovic joins Acadia Pharmaceuticals

He moves to the San Diego biopharma from Alkermes

San Diego biopharmaceutical company Acadia Pharmaceuticals has appointed Srdjan (Serge) Stankovic as executive vice president, head of research and development.

He joins the firm from Alkermes, where he most recently served as senior vice president of clinical development and medical affairs from 2013 to 2015.

Prior to this he worked at Teva as senior vice president and head of global clinical development following that company's acquisition of Cephalon, where he was senior vice president, worldwide clinical research. 

Stankovic has also held executive positions in research and development at Forest Laboratories, Neurogen, Johnson and Johnson and UCB.

Steve Davis, Acadia's president and chief executive officer, said: “Serge has a track record of transforming promising research into important medicines that address unmet needs of patients.

"We look forward to his contributions as we advance Nuplazid through NDA review for Parkinson's disease psychosis, prepare for the planned commercialisation of Nuplazid in the US  and continue our efforts to explore the full potential of Nuplazid to treat patients suffering from additional CNS disorders.” 

Nuplazid (pimavanserin), Acadia's lead candidate, has been submitted to the US FDA for a licence to treat Parkinson's disease psychosis, a condition that currently has no approved treatment.

Stankovic said: “There is a strong need for continued innovation in the treatment of CNS disorders such as Parkinson's disease, Alzheimer's disease, and schizophrenia. Acadia is at the forefront in developing groundbreaking medicines to treat debilitating symptoms associated with these diseases.

"I look forward to leading the team in advancing the promising development programmes with Nuplazid."

11th January 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics